Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression.

Lutchman M, Pack S, Kim AC, Azim A, Emmert-Buck M, van Huffel C, Zhuang Z, Chishti AH. Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression. Cancer Genet Cytogenet. 1999 Nov; 115(1):65-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.